Science | Nature | Cell | View More
Natural Products
Dehydroleucodine
Dehydroleucodine
ChemFaces products have been cited in many studies from excellent and top scientific journals
Product Name Dehydroleucodine
Price:
CAS No.: 36150-07-9
Catalog No.: CFN96587
Molecular Formula: C15H16O3
Molecular Weight: 244.29 g/mol
Purity: >=98%
Type of Compound: Sesquiterpenoids
Physical Desc.: Powder
Source: The aerial parts of Gynoxys verrucosa.
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Download: COA    MSDS
Similar structural: Comparison (Web)  (SDF)
Guestbook:
Contact Us
Order & Inquiry & Tech Support

Tel: (0086)-27-84237683
Tech: service@chemfaces.com
Order: manager@chemfaces.com
Address: 176, CheCheng Eest Rd., WETDZ, Wuhan, Hubei 430056, PRC
How to Order
Orders via your E-mail:

1. Product number / Name / CAS No.
2. Delivery address
3. Ordering/billing address
4. Contact information
Order: manager@chemfaces.com
Delivery time
Delivery & Payment method

1. Usually delivery time: Next day delivery by 9:00 a.m. Order now

2. We accept: Wire transfer & Credit card & Paypal
Citing Use of our Products
* Packaging according to customer requirements(5mg, 10mg, 20mg and more). We shipped via FedEx, DHL, UPS, EMS and others courier.
According to end customer requirements, ChemFaces provide solvent format. This solvent format of product intended use: Signaling Inhibitors, Biological activities or Pharmacological activities.
Size /Price /Stock 10 mM * 1 mL in DMSO / Inquiry
Other Packaging *Packaging according to customer requirements(100uL/well, 200uL/well and more), and Container use Storage Tube With Screw Cap
Our products had been exported to the following research institutions and universities, And still growing.
  • University of Illinois (USA)
  • The University of Newcastle (Australia)
  • Center for protein Engineering ... (Belgium)
  • National Research Council of Ca... (Canada)
  • Celltrion Chemical Research Ins... (Korea)
  • Massachusetts General Hospital (USA)
  • Deutsches Krebsforschungszentrum (Germany)
  • Worcester Polytechnic Institute (USA)
  • Chiang Mai University (Thailand)
  • University of Brasilia (Brazil)
  • Seoul National University (Korea)
  • More...
Package
Featured Products
Bisdemethoxycurcumin

Catalog No: CFN99186
CAS No: 33171-05-0
Price: $50/20mg
Kobophenol A

Catalog No: CFN92530
CAS No: 124027-58-3
Price: $318/10mg
Genistein

Catalog No: CFN98681
CAS No: 446-72-0
Price: $30/20mg
Triptolide

Catalog No: CFN99196
CAS No: 38748-32-2
Price: $118/20mg
Physalin B

Catalog No: CFN92941
CAS No: 23133-56-4
Price: $ / mg
Ganoderic acid H

Catalog No: CFN92056
CAS No: 98665-19-1
Price: $318/10mg
Diosmetin

Catalog No: CFN90210
CAS No: 520-34-3
Price: $30/20mg
Friedelin

Catalog No: CFN98936
CAS No: 559-74-0
Price: $218/10mg
Glycyrrhizic acid

Catalog No: CFN99151
CAS No: 1405-86-3
Price: $40/20mg
Fraxetin

Catalog No: CFN99113
CAS No: 574-84-5
Price: $30/20mg
Related Screening Libraries
Size /Price /Stock 10 mM * 100 uL in DMSO / Inquiry / In-stock
10 mM * 1 mL in DMSO / Inquiry / In-stock
Related Libraries
Biological Activity
Description: Dehydroleucodine has antidiarrheal, anti-inflammatory, anti-microbial, embryotoxicity, gastric cytoprotective, anti-cancer activities. Dehydroleucodine has an important inhibitory effect in cellular pathways regulating adipocyte differentiation by modulating the PPARγ expression, which is known to play a pivotal role during adipogenesis. Dehydroleucodine may be attributed to interference with multiple targets on the level of transcription factors, such as NF-kappaB, and cytokines. Dehydroleucodine induces a TP73-dependent transcriptional regulation of multiple cell death target genes in human glioblastoma cells.
Targets: PPAR | AMPK | ERK | Akt | NF-kB | Antifection
In vitro:
Cancer Lett. 2016 Mar 1;372(1):10-23.
Dehydroleucodine inhibits tumor growth in a preclinical melanoma model by inducing cell cycle arrest, senescence and apoptosis.[Pubmed: 26718258 ]
Malignant melanoma represents the fastest growing public health risk of all cancer types worldwide. Several strategies and anti-cancer drugs have been used in an effort to improve treatments, but the development of resistance to anti-neoplastic drugs remains the major cause of chemotherapy failure in melanomas. Previously, we showed that the sesquiterpene lactone, Dehydroleucodine (DhL), promotes the accumulation of DNA damage markers, such as H2AX and 53BP1, in human tumor cells. Also DhL was shown to trigger either cell senescence or apoptosis in a concentration-dependent manner in HeLa and MCF7 cells.
METHODS AND RESULTS:
Here, we evaluated the effects of DhL on B16F0 mouse melanoma cells in vitro and in a pre-clinical melanoma model. DhL inhibited the proliferation of B16F0 cells by inducing senescence or apoptosis in a concentration-dependent manner. Also, DhL reduced the expression of the cell cycle proteins cyclin D1 and B1 and the inhibitor of apoptosis protein, survivin. In melanomas generated by subcutaneous injection of B16F0 cells into C57/BL6 mice, the treatment with 20 mg DhL /Kg/day in preventive, simultaneous and therapeutic protocols reduced tumor volumes by 70%, 60% and 50%, respectively. DhL treatments reduced the number of proliferating, while increasing the number of senescent and apoptotic tumor cells. To estimate the long-term effects of DhL, a mathematical model was applied to fit experimental data.
CONCLUSIONS:
Extrapolation beyond experimental time points revealed that DhL administration following preventive and therapeutic protocols is predicted to be more effective than simultaneous treatments with DhL in restricting tumor growth.
J Ethnopharmacol. 2011 Sep 2;137(2):1055-9.
Sesquiterpene lactones from Gynoxys verrucosa and their anti-MRSA activity.[Pubmed: 21782013]
Because of its virulence and antibiotic resistance, Staphylococcus aureus is a more formidable pathogen now than at any time since the pre-antibiotic era. In an effort to identify and develop novel antimicrobial agents with activity against this pathogen, we have examined Gynoxys verrucosa Wedd (Asteraceae), an herb used in traditional medicine in southern Ecuador for the treatment and healing of wounds.
METHODS AND RESULTS:
The sesquiterpene lactones leucodine (1) and Dehydroleucodine (2) were extracted and purified from the aerial parts of Gynoxys verrucosa, and their structure was elucidated by spectroscopic methods and single-crystal X-ray analysis. The in vitro anti-microbial activity of Gynoxys verrucosa extracts and its purified constituents was determined against six clinical isolates including Staphylococcus aureus and Staphylococcus epidermidis strains with different drug-resistance profiles, using the microtiter broth method. Compound 1 has very low activity, while compound 2 has moderate activity with MIC(50)s between 49 and 195 μg/mL. The extract of Gynoxys verrucosa has weak activity with MIC(50)s between 908 and 3290 μg/mL.
CONCLUSIONS:
We are reporting the full assignment of the (1)H NMR and (13)C NMR of both compounds, and the crystal structure of compound 2, for the first time. Moreover, the fact that compound 2 has antimicrobial activity and compound 1 does not, demonstrates that the exocyclic conjugated methylene in the lactone ring is essential for the antimicrobial activity of these sesquiterpene lactones. However, the weak activity observed for the plant extracts, does not explain the use of Gynoxys verrucosa in traditional medicine for the treatment of wounds and skin infections.
In vivo:
Food Chem Toxicol. 2012 Mar;50(3-4):672-4.
Lethal effect of dehydroleucodine (DhL) on amphibian Bufo arenarum embryos.[Pubmed: 22240414 ]

METHODS AND RESULTS:
The Dehydroleucodine is a sesquiterpene lactone isolated from Artemisia douglasiana Besser which is used in popular medicine. Toxicity tests using embryos of amphibian have been widely used in order to predict toxic effects of different compounds. However, to our knowledge, there are not studies focussed on the toxic effects of Dehydroleucodine on Bufo arenarum, which is an anuran widely distributed in South America. The effect of Dehydroleucodine on the survival of embryos was evaluated in an acute test during the early life stage of B. arenarum embryos. Lethality and the degree of adverse effects were Dehydroleucodine dose-dependent.
CONCLUSIONS:
Overall, amphibian early life stages appeared to be more susceptible to the embryotoxicity associated with exposure to Dehydroleucodine, especially at concentration greater that 3mM. This increased susceptibility may result from the relatively high rate of cellular differentiation and morphogenesis that occurs at this early stage of development.
J Ethnopharmacol. 2003 Oct;88(2-3):195-8.
Anti-inflammatory activity and effect on gastric acid secretion of dehydroleucodine isolated from Artemisia douglasiana.[Pubmed: 12963142]

METHODS AND RESULTS:
The effect of Dehydroleucodine (DhL) on gastric acid secretion in rats was investigated at a dose of 40 mg/kg, while its anti-inflammatory effect was investigated in two experimental models: arthritis induced by Freund's adjuvant carrageenan- and cotton pellet-induced granuloma. DhL did not inhibit gastric acid secretion, suggesting that its anti-ulcerogenic effect can be attributed to its action on the mucosa defense factors. On the other hand, DhL inhibited both chronic and acute adjuvant carrageenan-induced inflammation phases, being most effective in the chronic phase. In the granuloma test, DhL also inhibited inflammation.
CONCLUSIONS:
It is suggested that the anti-inflammatory activity of DhL may be attributed to interference with multiple targets on the level of transcription factors, such as NF-kappaB, and cytokines.
Dehydroleucodine Description
Source: The aerial parts of Gynoxys verrucosa.
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Storage: Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

After receiving: The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
ChemFaces New Products and Compounds
Mahuannin E

Catalog No: CFN95585
CAS No: 1173887-70-1
Price: $318/5mg
3,7,23,24-tetrahydroxycucurbita-5,...

Catalog No: CFN95168
CAS No: 1446447-97-7
Price: $318/5mg
Gypenoside XIII

Catalog No: CFN95239
CAS No: 80325-22-0
Price: $288/10mg
Genistein 7-O-beta-D-glucopyranosi...

Catalog No: CFN95159
CAS No: 70404-42-1
Price: $318/10mg
cis-Mulberroside A

Catalog No: CFN95006
CAS No: 166734-06-1
Price: $418/10mg
1,4-Dihydroxy-2-carbomethoxy-3-pre...

Catalog No: CFN95100
CAS No: 1415729-43-9
Price: $318/10mg
Pinocembrin 7-O-(4'',6''-hexahydro...

Catalog No: CFN95462
CAS No: 1825287-22-6
Price: $318/10mg
Dihydrolicoisoflavone

Catalog No: CFN95073
CAS No: 164163-92-2
Price: $333/5mg
Recently, ChemFaces products have been cited in many studies from excellent and top scientific journals

Cell. 2018 Jan 11;172(1-2):249-261.e12.
doi: 10.1016/j.cell.2017.12.019.
IF=36.216(2019)

PMID: 29328914

Cell Metab. 2020 Mar 3;31(3):534-548.e5.
doi: 10.1016/j.cmet.2020.01.002.
IF=22.415(2019)

PMID: 32004475

Mol Cell. 2017 Nov 16;68(4):673-685.e6.
doi: 10.1016/j.molcel.2017.10.022.
IF=14.548(2019)

PMID: 29149595

ACS Nano. 2018 Apr 24;12(4): 3385-3396.
doi: 10.1021/acsnano.7b08969.
IF=13.903(2019)

PMID: 29553709

Nature Plants. 2016 Dec 22;3: 16206.
doi: 10.1038/nplants.2016.205.
IF=13.297(2019)

PMID: 28005066

Sci Adv. 2018 Oct 24;4(10): eaat6994.
doi: 10.1126/sciadv.aat6994.
IF=12.804(2019)

PMID: 30417089
Calculate Dilution Ratios(Only for Reference)
1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 4.0935 mL 20.4675 mL 40.935 mL 81.8699 mL 102.3374 mL
5 mM 0.8187 mL 4.0935 mL 8.187 mL 16.374 mL 20.4675 mL
10 mM 0.4093 mL 2.0467 mL 4.0935 mL 8.187 mL 10.2337 mL
50 mM 0.0819 mL 0.4093 mL 0.8187 mL 1.6374 mL 2.0467 mL
100 mM 0.0409 mL 0.2047 mL 0.4093 mL 0.8187 mL 1.0234 mL
* Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
Protocol
Kinase Assay:
Anticancer Agents Med Chem. 2017;17(6):839-850.
Dehydroleucodine Induces a TP73-dependent Transcriptional Regulation of Multiple Cell Death Target Genes in Human Glioblastoma Cells.[Pubmed: 27671304 ]
Dehydroleucodine, a natural sesquiterpene lactone from Artemisia douglassiana Besser (Argentine) and Gynoxys verrucosa (Ecuador). To define the molecular mechanisms underlying the effect of Dehydroleucodine on the human glioblastoma cells.
METHODS AND RESULTS:
Various techniques (cDNA expression array, real-time quantitative PCR, chromatin immunprecipitation, luciferase reporter assay, use of phosphospecific antibodies, immunoprecipitation, immunoblotting, apoptosis and autophagy assays) were employed to define and validate multiple molecular gene targets affected in human glioblastoma cells upon Dehydroleucodine exposure. Dehydroleucodine exposure upregulated the total and phosphorylated (p-Y99) levels of TP73 in U87- MG glioblastoma cells. We found that TP73 silencing led to a partial rescue of U87-MG cells from the cell death induced by Dehydroleucodine. Upon the Dehydroleucodine exposure numerous gene targets were upregulated and downregulated through a TP73-dependent transcriptional mechanism. Some of these gene targets are known to be involved in cell cycle arrest, apoptosis, autophagy and necroptosis. Dehydroleucodine induced the TP73 binding to the specific genes promoters (CDKN1A, BAX, TP53AIP1, CYLD, RIPK1, and APG5L). Moreover, the exposure of U87-MG cells to Dehydroleucodine upregulated the protein levels of CDKN1A, BAX, TP53AIP1, CYLD, RIPK1, APG5L, and downregulated the CASP8 level. The formation of RIPK1 protein complexes and phosphorylation of MLKL were induced by Dehydroleucodine supporting the notion of multiple cell death mechanisms implicated in the tumor cell response to Dehydroleucodine.
CONCLUSIONS:
This multifaceted study led to a conclusion that Dehydroleucodine induces the phosphorylation of tumor protein TP73 and in turn activates numerous TP73-target genes regulating apoptosis, autophagy and necroptosis in human glioblastoma cells.
Eur J Pharmacol. 2011 Dec 5;671(1-3):18-25.
The effect of dehydroleucodine in adipocyte differentiation.[Pubmed: 21963454 ]
Dehydroleucodine (DhL) is a sesquiterpene lactone of the guaianolide group with gastric cytoprotective activity. Recent studies have also demonstrated that DhL inhibits the proliferation of vascular smooth muscle cells.
METHODS AND RESULTS:
In this study we examined the effect of DhL in the differentiation of 3T3-L1 preadipocytes. The addition of DhL significantly inhibited the differentiation of 3T3-L1 preadipocytes along with a significant decrease in the accumulation of lipid content by a dramatic downregulation of the expression of adipogenic-specific transcriptional factors PPARγ and C-EBPα. However, phosphorylation of AMPKα, Erk1/2 and Akt1 was not inhibited by DhL treatment. Interestingly, we also found that 11,13-dihydroDehydroleucodine, a derivative of DhL with inactivated α-methylene-γ-lactone function, also inhibited the differentiation of 3T3-L1 preadipocytes.
CONCLUSIONS:
Taken together, these data suggest that DhL has an important inhibitory effect in cellular pathways regulating adipocyte differentiation by modulating the PPARγ expression, which is known to play a pivotal role during adipogenesis.
Cell Research:
Cell Mol Biol (Noisy-le-grand). 2005 Nov 8;51(6):525-30.
Dehydroleucodine inhibits vascular smooth muscle cell proliferation in G2 phase.[Pubmed: 16309576]
Vascular smooth muscle cell (VSMC) proliferation plays an important role in the development of atherosclerosis and in the vascular changes seen in hypertension. Dehydroleucodine (DhL) is a sesquiterpene lactone that inhibits cell proliferation in plant cells.
METHODS AND RESULTS:
In this paper, we study the effect of DhL in the proliferation of VSMCs stimulated with 10% fetal bovine serum (FBS). Very low concentrations of DhL (2-6 microM) inhibited VSMC proliferation and induced cell accumulation in G2. DhL did not affect the dynamics of 3H-thymidine incorporation, and did not modify either the activity of DNA polymerase or the incorporation of deoxyribonucleotides in an in vitro assay. Moreover, DhL did not induce apoptosis in VSMCs. These results indicate that DhL, in very low concentration, induces a transient arrest of VSMCs in G2.
CONCLUSIONS:
Our data show that VSMCs are especially sensitive to DhL effect, suggesting that DhL could be potentially useful to prevent the vascular pathological changes seen in hypertension and other vascular diseases.
Animal Research:
Fitoterapia. 2008 Jan;79(1):1-5.
Antidiarrheal activity of dehydroleucodine isolated from Artemisia douglasiana[Pubmed: 17683879 ]
Dehydroleucodine (DhL), a sesquiterpene lactone obtained from Artemisia douglasiana, was screened for antidiarrheal effects.
METHODS AND RESULTS:
DhL inhibited castor oil-induced diarrhea in mice by judged by a decrease in the number of wet faeces in the DhL-treatment groups. DhL significantly reduced intestinal transit in mice. Yohimbine and phentolamine counteracted the inhibitory effect of DhL. It is suggested that alpha2-adrenergic receptors mediate the effect of DhL in intestinal motility. DhL reduced also intraluminal accumulation of fluid.
CONCLUSIONS:
Thus, the antidiarrheal activity of DhL is possibly related, at least in part, to its inhibitory action against gastrointestinal motility and the inhibition of enteropooling property.
Bisdemethoxycurcumin

Catalog No: CFN99186
CAS No: 33171-05-0
Price: $50/20mg
Kobophenol A

Catalog No: CFN92530
CAS No: 124027-58-3
Price: $318/10mg
Genistein

Catalog No: CFN98681
CAS No: 446-72-0
Price: $30/20mg
Triptolide

Catalog No: CFN99196
CAS No: 38748-32-2
Price: $118/20mg
Physalin B

Catalog No: CFN92941
CAS No: 23133-56-4
Price: $ / mg
Ganoderic acid H

Catalog No: CFN92056
CAS No: 98665-19-1
Price: $318/10mg
Diosmetin

Catalog No: CFN90210
CAS No: 520-34-3
Price: $30/20mg
Friedelin

Catalog No: CFN98936
CAS No: 559-74-0
Price: $218/10mg
Glycyrrhizic acid

Catalog No: CFN99151
CAS No: 1405-86-3
Price: $40/20mg
Fraxetin

Catalog No: CFN99113
CAS No: 574-84-5
Price: $30/20mg
Tags: buy Dehydroleucodine | Dehydroleucodine supplier | purchase Dehydroleucodine | Dehydroleucodine cost | Dehydroleucodine manufacturer | order Dehydroleucodine | Dehydroleucodine distributor